4
Changes in Ownership
Climb Bio, Inc. Filed Acc 0000950170-24-108582
CHIEF ACCOUNTING OFFICER sold 1,191 shares at an average $8.18 ($9,741)
- CHIEF ACCOUNTING OFFICER acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pimblett Emily CHIEF ACCOUNTING OFFICER | 2024-09-18 | Option exercise 10b5-1 | +5,000 | 8,755 | D | ||
| Pimblett Emily CHIEF ACCOUNTING OFFICER | 2024-09-20 | Sale 10b5-1 | −1,182 | $8.18 | $9,669 | 7,573 | D |
| Pimblett Emily CHIEF ACCOUNTING OFFICER | 2024-09-20 | Sale 10b5-1 | −9 | $8.06 | $73 | 7,564 | D |
| Derivatives | |||||||
| Pimblett Emily CHIEF ACCOUNTING OFFICER | 2024-09-18 | Option exercise · Restricted Stock Units 10b5-1 | −5,000 | 30,000 | D | ||
| Open-market sales · 1,191 sh · avg $8.18 · $9,741 | |||||||
Loading xslF345X05/ownership.xml…